Roche Holding | ROG - Ebit




Roche Holding reported CHF11.29B in EBIT for its fiscal semester ending in June of 2024.

Ebit Change Date
AbbVie USD 5.33B 2.53B Dec/2024
Alcon AG USD 501M 171M Sep/2024
Almirall EUR 50.09M 65.59M Jun/2024
Amgen USD 4.03B 11M Dec/2024
AstraZeneca USD 4.2B 119M Dec/2024
Bayer EUR 267M 318M Sep/2024
Biogen USD 644.1M 100.9M Dec/2024
Bristol-Myers Squibb USD 4.21B 2.03B Dec/2024
Eli Lilly USD 5.63B 3.88B Dec/2024
Fresenius EUR 552M 287M Sep/2024
Fresenius Medical Care EUR 474M 31M Sep/2024
Galapagos EUR -62721000 8.42M Dec/2024
Genmab DKK 2.16B 58M Dec/2024
Gilead Sciences USD 3.11B 144M Dec/2024
GlaxoSmithKline GBP 1.43B 1.33B Dec/2024
GRIFOLS EUR 269.49M 73.1M Jun/2024
Hikma Pharmaceutical USD 402M 96M Jun/2024
Lonza CHF 727M 193M Dec/2024
Merck EUR 1.1B 240M Sep/2024
Merck USD 5.22B 805M Dec/2024
Novartis USD 4.86B 286M Dec/2024
Orion EUR 202M 136.2M Sep/2024
Pfizer USD 4.62B 2.42B Dec/2024
Philips EUR 637M 286M Dec/2024
Recordati EUR 134.8M 30.76M Dec/2024
Regeneron Pharmaceuticals USD 1.57B 67.9M Dec/2024
Roche Holding CHF 11.29B 2.68B Jun/2024
Sanofi EUR 2.08B 1.69B Dec/2024
UCB EUR 334M 163M Jun/2024